Biohaven (BHVN) EBT (2021 - 2026)

Biohaven has reported EBT for 6 years, with the latest figure at -$130.3 million in Q1 2026.

• Quarterly EBT rose 41.08% year-over-year to -$130.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$646.6 million (up 27.17% YoY) and the FY2025 annual result came in at -$737.4 million, up 12.81% from the prior year.
• EBT climbed to -$130.3 million in Q1 2026 per BHVN's latest filing, from -$145.2 million in the prior quarter.
• Over five years, EBT peaked at -$67.6 million in Q3 2022 and troughed at -$319.6 million in Q2 2024.
• A 5-year average of -$158.4 million and a median of -$160.4 million in 2024 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2023: EBT slumped 335.47% in 2022, then surged 55.28% in 2023.
• Over 5 years, EBT stood at -$215.2 million in 2022, then soared by 32.19% to -$146.0 million in 2023, then decreased by 27.97% to -$186.8 million in 2024, then increased by 22.27% to -$145.2 million in 2025, then rose by 10.29% to -$130.3 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$130.3 million, -$145.2 million, and -$173.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.